Hugel Inc (145020)

Currency in KRW
295,000
+6,500(+2.25%)
Delayed Data·
Earnings results expected in 6 days
145020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
285,500299,000
52 wk Range
208,500392,000
Key Statistics
Bid/Ask
294,500.00 / 295,000.00
Prev. Close
288,500
Open
296,500
Day's Range
285,500-299,000
52 wk Range
208,500-392,000
Volume
27.69K
Average Volume (3m)
85.81K
1-Year Change
27.2727%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
145020 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
352,600
Upside
+19.53%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Hugel Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Hugel Inc Company Profile

Hugel, Inc. develops and manufactures biopharmaceuticals in South Korea and internationally. The company offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults aged between 18 and 65; treatment of upper limb stroke; and treatment of dynamic equinus foot deformity in children with cerebral palsy over 2 years of age, as well as improvement of external angles of secondary ideals related to orbicularis oculi muscle activity in adults aged between 19 and 65 under the Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot brands. It also provides hyaluronic acid filler under the Dermalax, and The Chaeum brand names; cosmetics under the Wellage brand; and medical devices under BlueRose brand name. Hugel, Inc. was founded in 2001 and is headquartered in Chuncheon-si, South Korea.

Employees
594

Compare 145020 to Peers and Sector

Metrics to compare
145020
Peers
Sector
Relationship
P/E Ratio
21.9x−5.7x−0.6x
PEG Ratio
0.75−0.150.00
Price/Book
3.4x2.8x2.6x
Price / LTM Sales
7.7x11.2x3.4x
Upside (Analyst Target)
21.3%12.1%44.4%
Fair Value Upside
Unlock11.3%6.1%Unlock

Analyst Ratings

14 Buy
1 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 352,600
(+19.53% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Macquarie
Buy340,000.00+16.24%320,000.00MaintainJan 14, 2026
Morgan Stanley
Hold324,000.00+10.77%375,000.00MaintainJan 02, 2026
Macquarie
Buy320,000.00+9.40%440,000.00MaintainNov 06, 2025
Citi
Buy400,000.00+36.75%450,000.00MaintainOct 16, 2025
CLSA
Buy420,000.00+43.59%450,000.00UpgradeOct 13, 2025

Earnings

Latest Release
Nov 04, 2025
EPS / Forecast
2,941.00 / 3,176.30
Revenue / Forecast
105.90B / 116.19B
EPS Revisions
Last 90 days

145020 Income Statement

People Also Watch

423,500
196170
-1.51%
209,500
042700
+2.95%
104,200
000720
-4.14%
904,000
267260
+0.78%
247,500
086280
-3.13%

FAQ

What Is the Hugel (145020) Stock Price Today?

The Hugel stock price today is 295,000

What Stock Exchange Does Hugel Trade On?

Hugel is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Hugel?

The stock symbol for Hugel is "145020."

What Is the Hugel Market Cap?

As of today, Hugel market cap is 3.12T.

What Is Hugel's Earnings Per Share (TTM)?

The Hugel EPS (TTM) is 12,727.07.

When Is the Next Hugel Earnings Date?

Hugel will release its next earnings report on Feb 05, 2026.

From a Technical Analysis Perspective, Is 145020 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Hugel Stock Split?

Hugel has split 1 times.

How Many Employees Does Hugel Have?

Hugel has 594 employees.

What is the current trading status of Hugel (145020)?

As of Jan 30, 2026, Hugel (145020) is trading at a price of 295,000, with a previous close of 288,500. The stock has fluctuated within a day range of 285,500 to 299,000, while its 52-week range spans from 208,500 to 392,000.

What Is Hugel (145020) Price Target According to Analysts?

The average 12-month price target for Hugel is KRW352,600, with a high estimate of KRW400000 and a low estimate of KRW279000. 14 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +19.53% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.